BCB
Brian C. Broderick Portfolio holdings
AUM
$506M
This Quarter Return
-3.33%
1 Year Return
+12.39%
3 Year Return
+70.69%
5 Year Return
+110.99%
10 Year Return
+270.67%
AUM
$363M
AUM Growth
+$363M
(-4.2%)
Cap. Flow
+$1.04M
Cap. Flow
% of AUM
0.29%
Top 10 Holdings %
Top 10 Hldgs %
40.78%
Holding
83
New
2
Increased
36
Reduced
19
Closed
4
Top Buys
| 1 |
Amazon
AMZN
|
$1.22M |
| 2 |
UnitedHealth
UNH
|
$814K |
| 3 |
Airbnb
ABNB
|
$796K |
| 4 |
Medtronic
MDT
|
$521K |
| 5 |
Adobe
ADBE
|
$510K |
Top Sells
| 1 |
Honeywell
HON
|
$3.06M |
| 2 |
Welltower
WELL
|
$1.5M |
| 3 |
CVS Health
CVS
|
$1.14M |
| 4 |
PayPal
PYPL
|
$1.13M |
| 5 |
NVIDIA
NVDA
|
$677K |
Sector Composition
| 1 | Technology | 28.14% |
| 2 | Healthcare | 19.88% |
| 3 | Industrials | 11.55% |
| 4 | Consumer Discretionary | 9.02% |
| 5 | Consumer Staples | 5.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
PepsiCo
PEP
$203B
| $3.82M | 1.05% |
22,560
-495
| -2% | -$83.9K |
|
|
27
Honeywell
HON
$136B
| $3.5M | 0.96% |
18,920
-16,555
| -47% | -$3.06M |
|
|
28
CVS Health
CVS
$93B
| $3.29M | 0.91% |
47,173
-16,363
| -26% | -$1.14M |
|
29
Nike
NKE
$110B
| $3.2M | 0.88% |
33,423
+3,302
| +11% | +$316K |
|
30
Novartis
NVS
$248B
| $2.96M | 0.81% |
29,015
+1,425
| +5% | +$145K |
|
31
Church & Dwight Co
CHD
$22.7B
| $2.64M | 0.73% |
28,800
| – | – |
|
|
32
Medtronic
MDT
$118B
| $2.64M | 0.73% |
33,633
+6,647
| +25% | +$521K |
|
33
Aptiv
APTV
$17.3B
| $1.99M | 0.55% |
20,206
+4,694
| +30% | +$463K |
|
34
AbbVie
ABBV
$374B
| $1.82M | 0.5% |
12,197
-70
| -0.6% | -$10.4K |
|
35
Illumina
ILMN
$15.2B
| $1.78M | 0.49% |
12,953
+35
| +0.3% | +$4.81K |
|
36
SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$11B
| $1.52M | 0.42% |
29,000
| – | – |
|
|
37
Airbnb
ABNB
$76.5B
| $1.33M | 0.37% |
9,718
+5,798
| +148% | +$796K |
|
|
38
PayPal
PYPL
$66.5B
| $1.05M | 0.29% |
18,042
-19,288
| -52% | -$1.13M |
|
39
Becton Dickinson
BDX
$54.3B
| $1.04M | 0.29% |
4,040
+822
| +26% | +$213K |
|
|
40
Adobe
ADBE
$148B
| $1.02M | 0.28% |
2,000
+1,000
| +100% | +$510K |
|
41
Moderna
MRNA
$9.36B
| $992K | 0.27% |
9,600
+4,800
| +100% | +$496K |
|
42
HubSpot
HUBS
$24.9B
| $985K | 0.27% |
2,000
+1,000
| +100% | +$493K |
|
43
Trane Technologies
TT
$90.9B
| $794K | 0.22% |
3,915
-55
| -1% | -$11.2K |
|
44
Edwards Lifesciences
EW
$47.7B
| $761K | 0.21% |
10,980
-20
| -0.2% | -$1.39K |
|
45
Novo Nordisk
NVO
$252B
| $739K | 0.2% |
8,130
+3,820
| +89% | -$44.6K |
|
46
Bristol-Myers Squibb
BMY
$96.7B
| $679K | 0.19% |
11,700
| – | – |
|
47
Pembina Pipeline
PBA
$21.9B
| $671K | 0.18% |
22,324
+423
| +2% | +$12.7K |
|
48
CrowdStrike
CRWD
$104B
| $670K | 0.18% |
4,000
+2,000
| +100% | +$335K |
|
49
Merck
MRK
$210B
| $631K | 0.17% |
6,125
| – | – |
|
50
Thermo Fisher Scientific
TMO
$183B
| $496K | 0.14% |
980
| – | – |
|